753
Participants
Start Date
November 30, 2008
Primary Completion Date
March 31, 2009
Study Completion Date
November 30, 2010
Cell Culture-Derived H5N1 Subunit Influenza Vaccine, 3.75_0%MF59
Two vaccinations of Cell Culture-Derived H5N1 3.75 µg Subunit Influenza Vaccine containing 0% of MF59.
Cell Culture-Derived H5N1 Subunit Influenza Vaccine, 3.75_25%MF59
Two vaccinations of Cell Culture-Derived H5N1 3.75 µg Subunit Influenza Vaccine containing 25% of MF59.
Cell Culture-Derived H5N1 Subunit Influenza Vaccine, 3.75_50%MF59
Two vaccinations of Cell Culture-Derived H5N1 3.75 µg Subunit Influenza Vaccine containing 50% of MF59.
Cell Culture-Derived H5N1 Subunit Influenza Vaccine, 3.75_100%MF59
Two vaccinations of Cell Culture-Derived H5N1 3.75 µg Subunit Influenza Vaccine containing 100% of MF59.
Cell Culture-Derived H5N1 Subunit Influenza Vaccine, 7.5_0%MF59
Two vaccinations of Cell Culture-Derived H5N1 7.5 µg Subunit Influenza Vaccine containing 0% of MF59.
Cell Culture-Derived H5N1 Subunit Influenza Vaccine, 7.5_25%MF59
Two vaccinations of Cell Culture-Derived H5N1 7.5 µg Subunit Influenza Vaccine containing 25% of MF59.
Cell Culture-Derived H5N1 Subunit Influenza Vaccine, 7.5_50%MF59
Two vaccinations of Cell Culture-Derived H5N1 7.5 µg Subunit Influenza Vaccine containing 50% of MF59.
Cell Culture-Derived H5N1 Subunit Influenza Vaccine, 7.5_100%MF59
Two vaccinations of Cell Culture-Derived H5N1 7.5 µg Subunit Influenza Vaccine containing 100% of MF59.
Cell Culture-Derived H5N1 Subunit Influenza Vaccine, 15_0%MF59
Two vaccinations of Cell Culture-Derived H5N1 15 µg Subunit Influenza Vaccine containing 0% of MF59.
Cell Culture-Derived H5N1 Subunit Influenza Vaccine, 15_25%MF59
Two vaccinations of Cell Culture-Derived H5N1 15 µg Subunit Influenza Vaccine containing 25% of MF59.
Cell Culture-Derived H5N1 Subunit Influenza Vaccine, 15_50%MF59
Two vaccinations of Cell Culture-Derived H5N1 15 µg Subunit Influenza Vaccine containing 50% of MF59.
Cell Culture-Derived H5N1 Subunit Influenza Vaccine, 15_100%MF59
Two vaccinations of Cell Culture-Derived H5N1 15 µg Subunit Influenza Vaccine containing 100% of MF59.
Universitätsklinikum Gießen und Marburg GmbH, Giessen
Baylor College of Medicine, Houston
Collaborators (1)
Novartis Vaccines
INDUSTRY
Seqirus
INDUSTRY